CAPTRUST Financial Advisors
TLSI icon

CAPTRUST Financial Advisors’s TriSalus Life Sciences TLSI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.9K Buy
21,965
+131
+0.6% +$641 ﹤0.01% 2829
2025
Q4 		$152K Buy
21,834
+7
+0% +$39 ﹤0.01% 2562
2025
Q3 		$101K Buy
+21,827
New +$102K ﹤0.01% 2508

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

CAPTRUST Financial Advisors's TLSI Position: Q1 2026 in Review

CAPTRUST Financial Advisors increased its TriSalus Life Sciences (TLSI) stake by 0.6% in Q1 2026, buying an estimated $641 and bringing the position to 21,965 shares worth $87.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2829.

CAPTRUST Financial Advisors first reported a position in TLSI in Q3 2025 and has held it in 3 quarters since. The position peaked at $152K in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • CAPTRUST Financial Advisors held 21,965 shares of TriSalus Life Sciences worth $87.9K as of Q1 2026.
  • CAPTRUST Financial Advisors bought 131 TriSalus Life Sciences shares in Q1 2026, an estimated $641.
  • TriSalus Life Sciences made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2829 holding.
  • CAPTRUST Financial Advisors first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • CAPTRUST Financial Advisors's TriSalus Life Sciences position peaked at $152K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.